These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6479819)

  • 1. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors].
    Wahn V
    Fortschr Med; 1984 Aug; 102(31-32):795-8. PubMed ID: 6479819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V; Good RA; Gupta S; Pahwa S; Day NK
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
    Day NK; Good RA; Wahn V
    Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation].
    Sedlacek HH; Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the complement-binding activity of model immune complexes of different molecular weights].
    Konstantinova NA; Tumanova IA; Lavrent'ev VV; Petrov RV
    Biull Eksp Biol Med; 1984 May; 97(5):583-5. PubMed ID: 6722337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
    Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
    J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement-binding capacity of aggregated immunoglobulins of different molecular weights].
    Konstantinova NA; Ostreĭko KK; Tumanova IA; Lavret'ev VV; Petrov RV
    Biull Eksp Biol Med; 1982 Dec; 94(12):73-5. PubMed ID: 7150770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of systemic immunodeficiencies and the autoimmune process in the pathogenesis of chronic tonsillitis].
    Siegel G; Malberg K; Barthelmes H
    Allerg Immunol (Leipz); 1984; 30(2):91-103. PubMed ID: 6237561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
    Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
    Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation.
    Edberg JC; Kujala GA; Taylor RP
    J Immunol; 1987 Aug; 139(4):1240-4. PubMed ID: 3611789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anticomplementary activity of 2 intravenous gamma globulin preparations in children with acute lymphatic leukemia].
    Wahn V; von Kries R; Ebell W; Jürgens H; Göbel U
    Immun Infekt; 1984 Apr; 12(2):115-8. PubMed ID: 6442915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes.
    Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J
    Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and humoral immune parameters in bone marrow transplant recipients: effects of intravenous immunoglobulin administration.
    Späth PJ; Baumgartner C; Gratwohl A; Doran JE; Elisa A; Bachmann P; Scherz R; Berger C; Morell A; Tichelli A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3064-6. PubMed ID: 2495696
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for clinico-immunologic testing methods].
    Z Erkr Atmungsorgane; 1982; 159(3):309-21. PubMed ID: 6191446
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    Regal JF; Fraser DG; Toth CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus conference evaluates key issues concerning use of intravenous immune globulin.
    Clin Pharm; 1990 Jul; 9(7):489, 492-3. PubMed ID: 2198122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and therapy with immunoglobulin SRK].
    Schnoz M; Ryser DH; Barandun S; Eckmann L
    Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.